Quantcast

Industry news that matters to you.  Learn more

Chemoprevention Biomarker for Breast Cancer Identified

Researchers at Duke University Medical Center have identified a possible biomarker for measuring progress in breast cancer chemoprevention trials, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.

PNNL’s Richard Smith Named 2010 Scientist of the Year

Parkinson’s disease, cancer and biofuels production are just a few problems that biochemist Dick Smith has helped untangle in his long career of technological innovation and scientific insight. Now, R&D Magazine has honored Smith as 2010 Scientist of the Year for his many significant contributions to science.

Caris Life Sciences Expands Caris Target Now Biomarker Panel to Help Address Therapeutic Dilemmas Facing Nearly One Half of Breast Cancer Patients

Caris Life Sciences, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic services, today announced a significant expansion to the panel of breast cancer biomarkers analyzed by Caris Target Now. The expansion includes 14 new biomarkers that provide physicians with key information to help guide therapeutic decisions for an increased number of breast cancer patients, making the novel theranostic tool now potentially useful to approximately 50 percent of all women battling the disease.

Exagen Buys Cypress’ Diagnostics Business

Exagen Diagnostics Inc. acquired the medical diagnostics division of Cypress Bioscience Inc. in San Diego, Calif.

Novel Biomarker May Predict Response to New VEGF Receptor Inhibitor

Researchers believe there may be a way to predict, based on individual tumors, those patients that are more likely to respond to the investigational new drug tivozanib.